Description:

Osteoprotegerin(OPG) is identical to osteoclastogenesis inhibitory factor(OCIF), a soluble member of the tumor-necrosis factor receptor family that inhibits osteoclastogenesis. OPG is considered to play an important role in the regulation of bone resorption by modifying osteoclast differentiation. Osteoprotegerin is an independent risk factor for the progression of atherosclerosis and onset of cardiovascular disease. It can act as a soluble factor in the regulation of bone mass and imply a utility for OPG in the treatment of osteoporosis associated with increased osteoclast activity. OPG system may play a critical role in the development of osteolytic bone disease in multiple myeloma and that targeting this system may have therapeutic potential. OPG also plays a role in the vascular system.

Additional Information:

Name Related Product Names Short Description Immunogen Standard Range Sample Type Specimen/Volumes Swiss Prot Number Concentration Applications GI Number Stability Reactivity Kit Size Storage Intended Use

Mouse OPG ELISA Kit

MGC29565|MGC93568|OCIF|OPG|Osteoclastogenesis inhibitory factor|Osteoprotegerin|TNFRSF 11B|TNFRSF11B|TR 1|TR1|TR11B_HUMAN|Tumor necrosis factor receptor superfamily member 11B

Sandwich ELISA kit of Quantitative Detection for Mouse OPG

NSO, E22-L401

93.7pg/ml-6000pg/ml. Test has a sensitivity of

This kit is used for quantitative detection of mouse OPG in cell culture supernates, serum and plasma(EDTA).

Refer to Manual

O08712

Lot Specific

ELISA

18383

Four months at 4C and eight months at -20C.

Reactive to Mouse. There is no detectable cross-reactivity with other relevant proteins.

1x96 well plate

Store at 4°C for 6 months, at -20°C for 12 months. Avoid multiple freeze-thaw cycles(Shipped with wet ice.)

Research Use Only